Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co ROE % Adjusted to Book Value Chart
SHSE:600252 vs ZTS, UTHR: ROE % Adjusted to Book Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Guangxi Wuzhou Zhongheng Group Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangxi Wuzhou Zhongheng Group Co ROE % Adjusted to Book Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Guangxi Wuzhou Zhongheng Group Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Guangxi Wuzhou Zhongheng Group Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -1.64% mean?
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) has a ROE % Adjusted to Book Value of -1.64% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors.
Is Guangxi Wuzhou Zhongheng Group Co's ROE % Adjusted to Book Value too high?
Guangxi Wuzhou Zhongheng Group Co's current ROE % Adjusted to Book Value is -1.64%. Overall, Guangxi Wuzhou Zhongheng Group Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangxi Wuzhou Zhongheng Group Co's ROE % Adjusted to Book Value compare to ZTS and UTHR?
Guangxi Wuzhou Zhongheng Group Co's ROE % Adjusted to Book Value of -1.64% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. Guangxi Wuzhou Zhongheng Group Co's current ROE % Adjusted to Book Value is -1.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangxi Wuzhou Zhongheng Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.57, compared to a current price of ¥2.15 — trading 36.9% above its estimated fair value. The current ROE % Adjusted to Book Value is -1.64%. Guangxi Wuzhou Zhongheng Group Co's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Guangxi Wuzhou Zhongheng Group Co (SHSE:600252), the current ROE % Adjusted to Book Value is -1.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) Overvalued in 2026?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co stock appears to be overvalued.
The current stock price of ¥2.15 is trading 36.9% above its estimated GF Value™ of ¥1.57.
GuruFocus considers Guangxi Wuzhou Zhongheng Group Co to be Significantly Overvalued.
Key valuation signals for SHSE:600252:
ROE % Adjusted to Book Value: -1.64%
GF Value™: ¥1.57 vs. price of ¥2.15 (36.9% above fair value)
No single metric tells the full story. See the SHSE:600252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangxi Wuzhou Zhongheng Group Co Business Description
Guangxi Wuzhou Zhongheng Group Co Ltd is a Chinese company engaged in the production of Chinese medicines. The company is also involved in real estate and health foods.
39GF Score
Get the complete analysis for SHSE:600252
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600252 has been successfully added to your 
